By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the immediate health risk remains low to Americans, there are still ways that all of us can play a role in helping to prevent the spread of this and other viruses.
With that said, Clinilabs, the Sleep Disorders Institute and Snoosz.com are taking extra precautions to ensure the safety of our employees, our patients and our research subjects. Here are a few of the ways we are doing our part:
- In addition to our regular cleaning schedule, we will be disinfecting all door handles, phones, exam rooms, and countertops at least twice per day.
- Request that all employees, patients and research subjects wash their hands upon arrival at any of our offices. Washing hands often with soap and water is the best way to prevent exposure.
- Allowing some of our employees to work from home offices, when possible. Essential employees and physicians who need to see patients will remain available to our patients and research subjects, in person.
- Reviewing employee commuting schedules to see if staggered work schedules will help to limit exposure on mass transit.
- Minimizing face-to-face client meetings and conference attendance, and increasing our web meetings and webinars. By limiting employee travel, we limit exposure for our employees.
- Encouraging employees and all visitors to stay at home if they are not feeling well. If you must cancel your visit at the last minute due to illness, you will not be charged.
- Relocating emergency supplies of medical equipment, including CPAP machines
Here is what you can do to prevent the spread of this illness and other illnesses, including the flu:
- Wash your hands often with soap and water.
- Cover your mouth and nose when you cough or sneeze.
- Stay home when you are sick.
- See your doctor if you think you are ill.
Visit The Centers for Disease Control website for more information on the Coronavirus, including what you should know about symptoms, treatments, testing, and other frequently asked questions.
We are looking forward to continuing to support our patients, research subjects and clients as we navigate COVID-19 together.
Clinilabs Drug Development Corporation